Imatinib mesylate in the management of gastrointestinal stromal tumours (GIST) | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.06.2010 | Short review

Imatinib mesylate in the management of gastrointestinal stromal tumours (GIST)

verfasst von: G. P. Kurteva, P. F. Kurtev

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Current treatment of gastrointestinal stromal tumours

Nächster Artikel Pathology of gastrointestinal stromal tumours with accent to prognostic criteria

Titel: Imatinib mesylate in the management of gastrointestinal stromal tumours (GIST)
verfasst von: G. P. Kurteva
P. F. Kurtev
Publikationsdatum: 01.06.2010
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 2/2010
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-010-0195-6

Weitere Artikel der Ausgabe 2/2010

Adjuvant therapy with imatinib in GIST patients after radical surgery

Short review

Chronic lymphocytic leukaemia – emerging treatment options: a report from the ASH Meeting 2009

ASH report

Update on stem cell "plasticity"

Short review

Second-line targeted therapy of gastrointestinal stromal tumours

Short review

Insulin-like growth factor type I receptor: a new target in the treatment of non-small cell lung cancer patients

Short review

Short review – Management of Immune Thrombocytopenia in adults

Short review